Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) of the coxib class that functions as a highly selective inhibitor of the cyclooxygenase-2 (COX-2) enzyme. This medication is primarily indicated… Read more










![Chemical structure of 2-((4-(5-Chloro-6'-methyl-[2,3'-bipyridin]-3-yl)phenyl)sulfonyl)-1-(4-(methylsulfonyl)phenyl)ethan-1-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F646459-43-0-2-4-5-Chloro-6-methyl-23-bipyridin-3-ylphenylsulfonyl-1-4-methylsulfonylphenylethan-1-ol.png&w=3840&q=75)
![Chemical structure of 2-((4-(5-Chloro-6'-methyl-[2,3'-bipyridin]-3-yl)phenyl)sulfonyl)-1-(6-methylpyridin-3-yl)ethan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1817735-82-2-2-4-5-Chloro-6-methyl-23-bipyridin-3-ylphenylsulfonyl-1-6-methylpyridin-3-ylethan-1-one.png&w=3840&q=75)






![Chemical structure of 2-(5-Chloro-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-6'-yl)-1-(6-(methylsulfonyl)pyridin-3-yl)ethan-1-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F646459-47-4-2-5-Chloro-3-4-methylsulfonylphenyl-23-bipyridin-6-yl-1-6-methylsulfonylpyridin-3-ylethan-1-ol.png&w=3840&q=75)
![Chemical structure of 2-(5-Chloro-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-6'-yl)-1-(6-methylpyridin-3-yl)ethan-1-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F646459-40-7-2-5-Chloro-3-4-methylsulfonylphenyl-23-bipyridin-6-yl-1-6-methylpyridin-3-ylethan-1-ol.png&w=3840&q=75)














![Chemical structure of 5-(5'-Chloro-4,4''-bis(methylsulfonyl)-[1,1':3',1''-terphenyl]-2'-yl)-2-methylpyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F646459-51-0-5-5-Chloro-44-bismethylsulfonyl-1131-terphenyl-2-yl-2-methylpyridine.png&w=3840&q=75)



![Chemical structure of 5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridine] 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F325855-71-8-5-Chloro-6-methyl-3-4-methylsulfonylphenyl-23-bipyridine-1-oxide.png&w=3840&q=75)

![Chemical structure of 5-Chloro-6′-(methylsulfonyl)-3-[4-(methylsulfonyl)phenyl]-2,3′-bipyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F646459-49-6-5-Chloro-6-methylsulfonyl-3-4-methylsulfonylphenyl-23-bipyridine.png&w=3840&q=75)



![Chemical structure of 6'-Methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-5-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2901801-70-3-6-Methyl-3-4-methylsulfonylphenyl-23-bipyridin-5-amine.png&w=3840&q=75)

![Chemical structure of 6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F646459-41-8-6-Chloro-2-6-methyl-3-pyridinyl-3-4-methylsulfonylphenyl-18-naphthyridine.png&w=3840&q=75)



Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) of the coxib class that functions as a highly selective inhibitor of the cyclooxygenase-2 (COX-2) enzyme. This medication is primarily indicated for the management of inflammatory conditions and pain, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, chronic low back pain, and acute gouty arthritis. This category contains a comprehensive range of reference standards, including the active pharmaceutical ingredient, as well as related compounds such as process-related impurities, degradation products, metabolites, and stable isotope labelled compounds. These materials are critical for laboratories performing rigorous impurity profiling, method validation, and stability testing. By enabling the precise identification and quantification of analytes, these reference standards support consistent quality control and ensure adherence to international regulatory guidelines. Such tools are essential for maintaining data integrity during analytical research and the ongoing assessment of pharmaceutical product safety and efficacy.